Pioneering cellular medicines for women’s health
We’re developing off-the-shelf cell therapies for high-impact women’s diseases, with lead programs in ovarian cancer, triple negative breast cancer and endometriosis.
Pioneering excellence in the field of immunotherapy
Cartherics creates precisely-defined immunotherapy treatments to combat a variety of cancers, endometriosis and Alzheimer’s disease. We combine the best components of immune targeting utilising gene editing and CAR technology to advance cell therapy to provide more diverse off-the-shelf treatments for patients. Our team has strong backgrounds in research, development, and product commercialisation. And we partner with leading commercial and academic groups with complementary technology to push the boundaries of cell therapy for cancer and beyond.
Some of our partners
Latest news
New cancer immunotherapy approach turns immune cells into tiny anti-tumor drug factories
By Christine Filippis / December 20, 2018
https://www.eurekalert.org/pub_releases/2018-12/uoc--nci120418.php In lab and mouse experiments, UC San Diego School of Medicine researchers developed a method to leverage B cells...
Read More
‘Revolutionary’ cancer drug using genetically modified cells approved (Kymriah)
By Christine Filippis / December 19, 2018
Sydney Morning Herald (By Esther Han) 19 December 2018 — 12:00am https://www.smh.com.au/national/revolutionary-cancer-drug-using-genetically-modified-cells-approved-20181217-p50msk.html A revolutionary cancer therapy that supercharges a patient's...
Read More
Meet our newest recruit
By Christine Filippis / December 18, 2018
Research Assistant Callum Docherty explains why immunology is his passion and advancing cancer therapy is his goal. I’ve always had...
Read More
